CA2193836A1 - Vascular treatment method and apparatus - Google Patents

Vascular treatment method and apparatus

Info

Publication number
CA2193836A1
CA2193836A1 CA002193836A CA2193836A CA2193836A1 CA 2193836 A1 CA2193836 A1 CA 2193836A1 CA 002193836 A CA002193836 A CA 002193836A CA 2193836 A CA2193836 A CA 2193836A CA 2193836 A1 CA2193836 A1 CA 2193836A1
Authority
CA
Canada
Prior art keywords
congener
blood vessel
administering
coronary blood
extravascularly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002193836A
Other languages
French (fr)
Other versions
CA2193836C (en
Inventor
Stephen R. Igo
James W. Meador
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cormedics Corp
Original Assignee
Stephen R. Igo
James W. Meador
Cormedics Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stephen R. Igo, James W. Meador, Cormedics Corp. filed Critical Stephen R. Igo
Publication of CA2193836A1 publication Critical patent/CA2193836A1/en
Application granted granted Critical
Publication of CA2193836C publication Critical patent/CA2193836C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0587Epicardial electrode systems; Endocardial electrodes piercing the pericardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • A61N1/306Arrangements where at least part of the apparatus is introduced into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/105Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/12Blood circulatory system
    • A61M2210/122Pericardium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02Dilators made of swellable material

Abstract

A method and apparatus for treating blood vessels in a mammal, particularly humans, especially coronary blood vessels (3), for vascular thrombosis and angioplasty restenosis, thereby to decrease incidence of vessel re-thrombosis (3'), unstable angina and myocardial infarction, by administering (11, 15) a congener of an endothelium-derived bioactive agent, especially a nitrovasodilator, including one or more of nitric oxide or a nitric oxide donor agent, such as sodium nitroprusside and nitroglycerin, to an extravascular treatment site (4) at a therapeutically effective dosage rate.

Claims (23)

We claim:
1. A method of treating blood vessels in a mammal, which comprises administering a congener of an endothelium-derived bioactive agent to an extravascular treatment site at a therapeutically effective dosage rate.
2. The method of claim 1 in which said congener is prostacyclin, prostaglandin E1, or a nitrovasodilator.
3. The method of claim 2 in which said nitrovasodilator is nitric oxide or a nitric oxide donor agent.
4. The method of claim 3 in which said nitric oxide donor agent is L-arginine, sodium nitroprusside or nitroglycerin, or a combination thereof.
5. The method of claim 1 in which said congener is sodium nitroprusside.
6. The method of claim 1 in which said treatment site is a coronary blood vessel.
7. The method of claim 6 in which said treatment site is a coronary artery.
8. The method of claim 6 in which said treatment site is a vein graft for arterial bypass.
9. The method of claim 1 in which said step of administering includes deliveringsaid congener in a controlled manner over a sustained period of time.
10. The method of claim 6 in which said step of administering comprises intrapericardially extravascularly delivering said congener to said coronary blood vessel.
11. The method of claim 10 in which said step of administering comprises intrapericardially infusing said congener through a percutaneously inserted catheter extravascularly to said coronary blood vessel.
12. The method of claim 6 in which said step of administering comprises transpericardially extravascularly delivering said congener to said coronary blood vessel.
13. The method of claim 12 in which said step of administering comprises transpericardially infusing said congener through a percutaneously inserted catheter extravascularly to said coronary blood vessel.
14. The method of claim 12 in which said step of administering comprises iontophoretically delivering said congener transpericardially extravascularly to said coronary blood vessel,
IS. The method of claim 6 in which said step of administering comprises inserting extravascularly to said coronary blood vessel an implant capable of extended time release of said congener.
16. The method of claim 15 in which said step of inserting said extravascular implant comprises percutaneously inserting said implant proximately adjacent, onto, or into the pericardial sac surrounding the heart.
17. The method of claim 15 in which step of inserting said extravascular implantcomprises surgically wrapping said implant around a vein graft used for an arterial bypass.
18. The method of claim 15 in which said extravascular implant is a biodegradable controlled-release polymer comprising said congener.
19. The method of claim 1 in which said dosage rate is effective to provide one or more of the therapeutic effects of promotion of vasodilation, inhibition of vessel spasm, inhibition of platelet aggregation, inhibition of vessel thrombosis, and inhibition of platelet growth factor release, at said treatment sites, without inducing systemic hypotension or anticoagulation.
20. The method of claim 1 in which said dosage rate is from about 0.1 to about 3.0 µg/kg/min.
21. A method of treating a coronary blood vessel in a mammal, which comprises intrapericardially or transpericardially supplying sodium nitroprusside to the blood vessel in a therapeutically effective dose.
22. A method of treating the heart, which comprises administering a cardio-active or cardio-vascular active drug from the pericardial space.
23. The method of claim 22 in which said drug is selected from vasodilator, antiplatelet, anticoagulant, thrombolytic, anti-inflammatory, antiarrhythmic, inotropic, antimitotic, angiogenic, antiatherogenic and gene therapy agents.
CA2193836A 1994-06-23 1995-06-23 Vascular treatment method and apparatus Expired - Fee Related CA2193836C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/264,458 US5681278A (en) 1994-06-23 1994-06-23 Coronary vasculature treatment method
US08/264,458 1994-06-23
PCT/US1995/009055 WO1996000112A1 (en) 1994-06-23 1995-06-23 Vascular treatment method and apparatus

Publications (2)

Publication Number Publication Date
CA2193836A1 true CA2193836A1 (en) 1996-01-04
CA2193836C CA2193836C (en) 2010-03-30

Family

ID=23006161

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2193836A Expired - Fee Related CA2193836C (en) 1994-06-23 1995-06-23 Vascular treatment method and apparatus

Country Status (8)

Country Link
US (2) US5681278A (en)
EP (1) EP0766580B1 (en)
JP (1) JPH10507092A (en)
AT (1) ATE318164T1 (en)
AU (2) AU3134495A (en)
CA (1) CA2193836C (en)
DE (1) DE69534798T2 (en)
WO (2) WO1996000038A1 (en)

Families Citing this family (229)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6161543A (en) 1993-02-22 2000-12-19 Epicor, Inc. Methods of epicardial ablation for creating a lesion around the pulmonary veins
US5891459A (en) * 1993-06-11 1999-04-06 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US5861168A (en) * 1993-06-11 1999-01-19 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
US6152141A (en) * 1994-07-28 2000-11-28 Heartport, Inc. Method for delivery of therapeutic agents to the heart
US6425881B1 (en) * 1994-10-05 2002-07-30 Nitrosystems, Inc. Therapeutic mixture useful in inhibiting lesion formation after vascular injury
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
US20110196039A9 (en) * 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US5968983A (en) * 1994-10-05 1999-10-19 Nitrosystems, Inc Method and formulation for treating vascular disease
US6063407A (en) * 1995-02-16 2000-05-16 The General Hospital Corporation Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US5897553A (en) 1995-11-02 1999-04-27 Medtronic, Inc. Ball point fluid-assisted electrocautery device
US6322548B1 (en) 1995-05-10 2001-11-27 Eclipse Surgical Technologies Delivery catheter system for heart chamber
US5827216A (en) 1995-06-07 1998-10-27 Cormedics Corp. Method and apparatus for accessing the pericardial space
US5797870A (en) * 1995-06-07 1998-08-25 Indiana University Foundation Pericardial delivery of therapeutic and diagnostic agents
US5900433A (en) * 1995-06-23 1999-05-04 Cormedics Corp. Vascular treatment method and apparatus
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
EP1264601A3 (en) * 1995-11-01 2003-11-12 Chiron Corporation Treatment of a coronary condition by delivery of therapeutics to the pericardial space
WO1997016169A1 (en) * 1995-11-01 1997-05-09 Chiron Corporation Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space
DE69637676D1 (en) * 1995-11-09 2008-10-23 Univ R Use of locally administered lysines to IMPROVE VASCULAR FUNCTION
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ.ヴイ. Electric muscle control device
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US8321013B2 (en) 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US6258032B1 (en) * 1997-01-29 2001-07-10 William M. Hammesfahr Method of diagnosis and treatment and related compositions and apparatus
US7840264B1 (en) 1996-08-19 2010-11-23 Mr3 Medical, Llc System and method for breaking reentry circuits by cooling cardiac tissue
US7908003B1 (en) 1996-08-19 2011-03-15 Mr3 Medical Llc System and method for treating ischemia by improving cardiac efficiency
US7052493B2 (en) 1996-10-22 2006-05-30 Epicor Medical, Inc. Methods and devices for ablation
US6237605B1 (en) 1996-10-22 2001-05-29 Epicor, Inc. Methods of epicardial ablation
US6311692B1 (en) 1996-10-22 2001-11-06 Epicor, Inc. Apparatus and method for diagnosis and therapy of electrophysiological disease
US6805128B1 (en) 1996-10-22 2004-10-19 Epicor Medical, Inc. Apparatus and method for ablating tissue
US6840936B2 (en) 1996-10-22 2005-01-11 Epicor Medical, Inc. Methods and devices for ablation
US6719755B2 (en) 1996-10-22 2004-04-13 Epicor Medical, Inc. Methods and devices for ablation
US6206004B1 (en) 1996-12-06 2001-03-27 Comedicus Incorporated Treatment method via the pericardial space
ATE449836T1 (en) 1997-02-10 2009-12-15 Harvard College METHOD FOR MODULATING HEMATOPOASIS AND VASCULAR GROWTH
US6045565A (en) * 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6086582A (en) * 1997-03-13 2000-07-11 Altman; Peter A. Cardiac drug delivery system
US6443949B2 (en) * 1997-03-13 2002-09-03 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
US6511477B2 (en) 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
CA2225013C (en) 1997-04-04 2006-06-06 Institut Du N.O. Inc. Injection system for delivery of a gaseous substance
US5984908A (en) * 1997-04-10 1999-11-16 Chase Medical Inc Venous return catheter having integral support member
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US6004295A (en) * 1997-06-26 1999-12-21 An-Go-Gen Inc. Catheters
AU3458197A (en) * 1997-07-16 1999-02-10 Impulse Dynamics N.V. Smooth muscle controller
US6096037A (en) 1997-07-29 2000-08-01 Medtronic, Inc. Tissue sealing electrosurgery device and methods of sealing tissue
JP2001513495A (en) * 1997-08-08 2001-09-04 デューク ユニバーシティ Compositions, devices and methods that facilitate surgical procedures
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US5972013A (en) * 1997-09-19 1999-10-26 Comedicus Incorporated Direct pericardial access device with deflecting mechanism and method
US6592552B1 (en) 1997-09-19 2003-07-15 Cecil C. Schmidt Direct pericardial access device and method
US6436365B2 (en) * 1997-09-23 2002-08-20 Schering Aktiengesellschaft Process for therapeutic treatment of proliferative diseases
US8709007B2 (en) 1997-10-15 2014-04-29 St. Jude Medical, Atrial Fibrillation Division, Inc. Devices and methods for ablating cardiac tissue
EP1037621A4 (en) 1997-10-15 2004-01-21 Univ Jefferson Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6575956B1 (en) 1997-12-31 2003-06-10 Pharmasonics, Inc. Methods and apparatus for uniform transcutaneous therapeutic ultrasound
US7921855B2 (en) * 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US6221425B1 (en) 1998-01-30 2001-04-24 Advanced Cardiovascular Systems, Inc. Lubricious hydrophilic coating for an intracorporeal medical device
US6296630B1 (en) 1998-04-08 2001-10-02 Biocardia, Inc. Device and method to slow or stop the heart temporarily
US6527767B2 (en) * 1998-05-20 2003-03-04 New England Medical Center Cardiac ablation system and method for treatment of cardiac arrhythmias and transmyocardial revascularization
US6231518B1 (en) 1998-05-26 2001-05-15 Comedicus Incorporated Intrapericardial electrophysiological procedures
JP2002516134A (en) 1998-05-26 2002-06-04 コメディカス・インコーポレーテッド Endocardial treatment method and device
US6706039B2 (en) 1998-07-07 2004-03-16 Medtronic, Inc. Method and apparatus for creating a bi-polar virtual electrode used for the ablation of tissue
US6537248B2 (en) 1998-07-07 2003-03-25 Medtronic, Inc. Helical needle apparatus for creating a virtual electrode used for the ablation of tissue
US6152911A (en) * 1998-08-27 2000-11-28 Chase Medical, Inc. Venous return catheter having multiple helical support members
CA2341683C (en) * 1998-09-11 2015-07-21 President And Fellows Of Harvard College Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
US8308719B2 (en) 1998-09-21 2012-11-13 St. Jude Medical, Atrial Fibrillation Division, Inc. Apparatus and method for ablating tissue
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8019421B2 (en) * 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US6319244B2 (en) 1999-03-16 2001-11-20 Chase Medical, L.P. Catheter with flexible and rigid reinforcements
US6488689B1 (en) * 1999-05-20 2002-12-03 Aaron V. Kaplan Methods and apparatus for transpericardial left atrial appendage closure
US7190997B1 (en) * 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7092753B2 (en) * 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
AU774185B2 (en) * 1999-06-05 2004-06-17 Board Of Trustees Of The Leland Stanford Junior University Method and composition for inhibiting cardiovascular cell proliferation
US6746481B1 (en) 1999-06-28 2004-06-08 Medtronic, Inc. Implatable device including a polyamino acid component
CA2377583A1 (en) 1999-07-19 2001-01-25 Epicor, Inc. Apparatus and method for ablating tissue
US7288096B2 (en) 2003-01-17 2007-10-30 Origin Medsystems, Inc. Apparatus for placement of cardiac defibrillator and pacer
US7398781B1 (en) 1999-08-10 2008-07-15 Maquet Cardiovascular, Llc Method for subxiphoid endoscopic access
US7597698B2 (en) 1999-08-10 2009-10-06 Maquet Cardiovascular Llc Apparatus and method for endoscopic encirclement of pulmonary veins for epicardial ablation
US6569082B1 (en) 1999-08-10 2003-05-27 Origin Medsystems, Inc. Apparatus and methods for cardiac restraint
US7526342B2 (en) 1999-08-10 2009-04-28 Maquet Cardiovascular Llc Apparatus for endoscopic cardiac mapping and lead placement
US20030187460A1 (en) * 1999-08-10 2003-10-02 Chin Albert K. Methods and apparatus for endoscopic cardiac surgery
US20030187461A1 (en) * 1999-08-10 2003-10-02 Chin Albert K. Releasable guide and method for endoscopic cardiac lead placement
US20060287574A1 (en) * 1999-08-25 2006-12-21 Chin Albert K Longitudinal dilator
US6587718B2 (en) * 1999-10-08 2003-07-01 Scimed Life Systems, Inc. Iontophoretic delivery to heart tissue
US20050154370A1 (en) 1999-10-29 2005-07-14 Medtronic, Inc. Methods and systems for providing therapies into the pericardial space
US20040121942A1 (en) * 1999-11-02 2004-06-24 Kenneth Chien Method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure
US20030229331A1 (en) * 1999-11-05 2003-12-11 Pharmasonics, Inc. Methods and apparatus for uniform transcutaneous therapeutic ultrasound
AU2623201A (en) * 1999-12-30 2001-07-16 Kam W Leong Controlled delivery of therapeutic agents by insertable medical devices
US8221402B2 (en) 2000-01-19 2012-07-17 Medtronic, Inc. Method for guiding a medical device
US7706882B2 (en) 2000-01-19 2010-04-27 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area
ATE460951T1 (en) * 2000-01-25 2010-04-15 Edwards Lifesciences Corp RELEASE SYSTEMS FOR THE TREATMENT OF RESTENOSIS AND ANASTOMOTIC INTIMAL HYPERPLASIA
US8048070B2 (en) 2000-03-06 2011-11-01 Salient Surgical Technologies, Inc. Fluid-assisted medical devices, systems and methods
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
US6514250B1 (en) 2000-04-27 2003-02-04 Medtronic, Inc. Suction stabilized epicardial ablation devices
AU2001253654A1 (en) 2000-04-27 2001-11-12 Medtronic, Inc. Vibration sensitive ablation apparatus and method
US7498304B2 (en) * 2000-06-16 2009-03-03 Curis, Inc. Angiogenesis-modulating compositions and uses
AU7549501A (en) * 2000-06-16 2002-01-02 Biogen Inc Angiogenesis-modulating compositions and uses
US6685672B1 (en) 2000-07-13 2004-02-03 Edwards Lifesciences Corporation Multi-balloon drug delivery catheter for angiogenesis
WO2002017809A1 (en) * 2000-08-29 2002-03-07 Kaplan Aaron V Methods and apparatus for transpericardial left atrial appendage closure
US6726920B1 (en) 2000-09-22 2004-04-27 Durect Corporation Implantable drug delivery patch
US6690970B1 (en) 2000-10-06 2004-02-10 Syde A. Taheri Biological pacemaker and implantation catheter
US6926669B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Heart wall ablation/mapping catheter and method
US20050084514A1 (en) * 2000-11-06 2005-04-21 Afmedica, Inc. Combination drug therapy for reducing scar tissue formation
EP1341476A2 (en) * 2000-12-01 2003-09-10 Nephros Therapeutics, Inc. Intrasvascular drug delivery device and use therefor
US6692458B2 (en) * 2000-12-19 2004-02-17 Edwards Lifesciences Corporation Intra-pericardial drug delivery device with multiple balloons and method for angiogenesis
US20040138621A1 (en) 2003-01-14 2004-07-15 Jahns Scott E. Devices and methods for interstitial injection of biologic agents into tissue
US7740623B2 (en) 2001-01-13 2010-06-22 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US6699240B2 (en) 2001-04-26 2004-03-02 Medtronic, Inc. Method and apparatus for tissue ablation
US6663627B2 (en) 2001-04-26 2003-12-16 Medtronic, Inc. Ablation system and method of use
US7959626B2 (en) 2001-04-26 2011-06-14 Medtronic, Inc. Transmural ablation systems and methods
US6807968B2 (en) 2001-04-26 2004-10-26 Medtronic, Inc. Method and system for treatment of atrial tachyarrhythmias
EP1383447A4 (en) * 2001-04-27 2007-04-04 Medstar Res Inst Stent-based delivery of statins to prevent restenosis
JP2003007916A (en) * 2001-06-19 2003-01-10 Sanyo Electric Co Ltd Method of manufacturing circuit device
US8934968B2 (en) * 2001-08-03 2015-01-13 Cardiac Pacemakers, Inc. Neurostimulation and coronary artery disease treatment
US7481759B2 (en) * 2001-08-03 2009-01-27 Cardiac Pacemakers, Inc. Systems and methods for treatment of coronary artery disease
JP4341907B2 (en) 2001-09-05 2009-10-14 セイリアント・サージカル・テクノロジーズ・インコーポレーテッド Fluid-assisted medical device, system and method
US20030077310A1 (en) * 2001-10-22 2003-04-24 Chandrashekhar Pathak Stent coatings containing HMG-CoA reductase inhibitors
US6936040B2 (en) * 2001-10-29 2005-08-30 Medtronic, Inc. Method and apparatus for endovenous pacing lead
US7967816B2 (en) 2002-01-25 2011-06-28 Medtronic, Inc. Fluid-assisted electrosurgical instrument with shapeable electrode
US6889091B2 (en) 2002-03-06 2005-05-03 Medtronic, Inc. Method and apparatus for placing a coronary sinus/cardiac vein pacing lead using a multi-purpose side lumen
US7610104B2 (en) * 2002-05-10 2009-10-27 Cerebral Vascular Applications, Inc. Methods and apparatus for lead placement on a surface of the heart
US7118566B2 (en) 2002-05-16 2006-10-10 Medtronic, Inc. Device and method for needle-less interstitial injection of fluid for ablation of cardiac tissue
US7294143B2 (en) 2002-05-16 2007-11-13 Medtronic, Inc. Device and method for ablation of cardiac tissue
JP4265888B2 (en) * 2002-06-12 2009-05-20 株式会社リコー Image forming apparatus
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7083620B2 (en) 2002-10-30 2006-08-01 Medtronic, Inc. Electrosurgical hemostat
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
JP2006519663A (en) 2003-03-10 2006-08-31 インパルス ダイナミックス エヌヴイ Apparatus and method for delivering electrical signals for regulating gene expression in heart tissue
US7497857B2 (en) 2003-04-29 2009-03-03 Medtronic, Inc. Endocardial dispersive electrode for use with a monopolar RF ablation pen
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US7846168B2 (en) 2003-10-09 2010-12-07 Sentreheart, Inc. Apparatus and method for the ligation of tissue
US20080085329A1 (en) * 2003-10-22 2008-04-10 Fred Hutchinson Cancer Research Center, Inc. Methods, Compositions and Devices for Inducing Stasis in Cells, Tissues, Organs, and Organisms
US20050165452A1 (en) * 2004-01-28 2005-07-28 Medtronic, Inc. Antithrombogenic medical device
US7186214B2 (en) * 2004-02-12 2007-03-06 Medtronic, Inc. Instruments and methods for accessing an anatomic space
US20050192210A1 (en) * 2004-03-01 2005-09-01 Rothbard Jonathan B. Compositions and methods for treating diseases
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
WO2005087295A2 (en) * 2004-03-18 2005-09-22 Ino Medics Ltd. Delivery of nitric oxide to a blood vessel
EP1730280B1 (en) * 2004-03-26 2018-10-24 Curis, Inc. Rna interference modulators of hedgehog signaling and uses thereof
WO2005107765A2 (en) * 2004-05-05 2005-11-17 Cormedics Corporation Heart treatment method
US8333764B2 (en) 2004-05-12 2012-12-18 Medtronic, Inc. Device and method for determining tissue thickness and creating cardiac ablation lesions
WO2005112812A1 (en) 2004-05-14 2005-12-01 Medtronic, Inc. Method and devices for treating atrial fibrillation by mass ablation
US20050266042A1 (en) * 2004-05-27 2005-12-01 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysmal tissue
WO2005120374A1 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Compound bipolar ablation device and method
ATE516762T1 (en) 2004-06-02 2011-08-15 Medtronic Inc ABLATION AND STAPLE INSTRUMENT
EP1750608B1 (en) 2004-06-02 2012-10-03 Medtronic, Inc. Ablation device with jaws
WO2005120375A2 (en) 2004-06-02 2005-12-22 Medtronic, Inc. Loop ablation apparatus and method
US8409219B2 (en) 2004-06-18 2013-04-02 Medtronic, Inc. Method and system for placement of electrical lead inside heart
US8663245B2 (en) 2004-06-18 2014-03-04 Medtronic, Inc. Device for occlusion of a left atrial appendage
US8926635B2 (en) * 2004-06-18 2015-01-06 Medtronic, Inc. Methods and devices for occlusion of an atrial appendage
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EP1827571B1 (en) 2004-12-09 2016-09-07 Impulse Dynamics NV Protein activity modification
WO2006099244A1 (en) * 2005-03-11 2006-09-21 Hong Kong Nitric Oxide Limited Combination therapy for endothelial dysfunction, angina and diabetes
US8244371B2 (en) 2005-03-18 2012-08-14 Metacure Limited Pancreas lead
WO2006110734A2 (en) 2005-04-07 2006-10-19 Sentreheart, Inc. Apparatus and method for the ligation of tissue
US8822535B2 (en) * 2005-04-20 2014-09-02 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US8932208B2 (en) 2005-05-26 2015-01-13 Maquet Cardiovascular Llc Apparatus and methods for performing minimally-invasive surgical procedures
US20070010781A1 (en) * 2005-06-27 2007-01-11 Venkataramana Vijay Implantable aorto-coronary sinus shunt for myocardial revascularization
CN101563097A (en) * 2005-11-14 2009-10-21 企业合伙人风险资本公司 Stem cell factor therapy for tissue injury
EP1989144A4 (en) 2006-02-02 2014-01-29 Innovative Bio Therapies An extracorporeal cell-based therapeutic device and delivery system
US20080039746A1 (en) 2006-05-25 2008-02-14 Medtronic, Inc. Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
US20080039362A1 (en) * 2006-08-09 2008-02-14 Afmedica, Inc. Combination drug therapy for reducing scar tissue formation
US20080085293A1 (en) * 2006-08-22 2008-04-10 Jenchen Yang Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8012143B1 (en) 2006-12-12 2011-09-06 Pacesetter, Inc. Intrapericardial delivery tools and methods
PL2574287T3 (en) 2007-03-30 2015-10-30 Sentreheart Inc Devices for closing the left atrial appendage
US20080294175A1 (en) * 2007-05-21 2008-11-27 Epitek, Inc. Left atrial appendage closure
WO2008147678A1 (en) * 2007-05-21 2008-12-04 Epitek, Inc. Left atrial appendage closure
US20090036965A1 (en) * 2007-07-30 2009-02-05 Robert Glenmore Walsh Conjunctive stent therapy
US20090036875A1 (en) * 2007-07-30 2009-02-05 Robert Glenmore Walsh Cardiac tissue therapy
EP3272297B1 (en) 2007-09-20 2020-04-22 Sentreheart, Inc. Devices for remote suture management
EP2209517A4 (en) 2007-10-05 2011-03-30 Maquet Cardiovascular Llc Devices and methods for minimally-invasive surgical procedures
US20090170933A1 (en) * 2007-12-26 2009-07-02 Cook Incorporated Method for removing a medical device from a spasmodic constriction in a bodily passageway
JP5443386B2 (en) 2007-12-28 2014-03-19 サリエント・サージカル・テクノロジーズ・インコーポレーテッド Fluid-assisted electrosurgical device, method and system
US8821488B2 (en) 2008-05-13 2014-09-02 Medtronic, Inc. Tissue lesion evaluation
US9603674B2 (en) * 2008-05-30 2017-03-28 The Regents Of The University Of California Method to protect the esophagus and other mediastinal structures during cardiac and thoracic interventions
EP2291515A2 (en) 2008-06-18 2011-03-09 Innovative Biotherapies, Inc. Methods for propagation of renal precursor cells
ES2440751T3 (en) * 2008-10-07 2014-01-30 Boston Scientific Scimed, Inc. Medical devices for administration of therapeutic agents to body lumens
US20100094277A1 (en) * 2008-10-09 2010-04-15 Olympus Medical Systems Corp. High-frequency surgical device and method
US11660430B2 (en) * 2008-10-10 2023-05-30 Peter Forsell Heart assisting device
JP5855460B2 (en) 2008-11-24 2016-02-09 ヴァスキュラー グラフト ソリューションズ リミテッド External stent
US9254168B2 (en) 2009-02-02 2016-02-09 Medtronic Advanced Energy Llc Electro-thermotherapy of tissue using penetrating microelectrode array
WO2010096809A1 (en) 2009-02-23 2010-08-26 Salient Surgical Technologies, Inc. Fluid-assisted electrosurgical device and methods of use thereof
WO2010105081A1 (en) * 2009-03-13 2010-09-16 Medtronic, Inc. Method of treating heart failure
JP5612073B2 (en) 2009-04-01 2014-10-22 センターハート・インコーポレイテッドSentreHEART, Inc. Tissue ligation apparatus and its operation
WO2011031299A1 (en) * 2009-08-28 2011-03-17 Mount Sinai School Of Medicine Of New York University Intrapericardial injections
CN102497832B (en) 2009-09-08 2015-09-09 显著外科技术公司 For case assembly and the using method thereof of electro-surgical device, electrosurgical unit
EP2351529B1 (en) * 2010-01-27 2019-06-05 Aeeg Ab Post operative wound support device
WO2011092710A2 (en) 2010-02-01 2011-08-04 Metacure Limited Gastrointestinal electrical therapy
EP2544616B1 (en) 2010-03-11 2017-09-06 Medtronic Advanced Energy LLC Bipolar electrosurgical cutter with position insensitive return electrode contact
WO2011129893A1 (en) 2010-04-13 2011-10-20 Sentreheart, Inc. Methods and devices for treating atrial fibrillation
EP2422823B1 (en) * 2010-07-30 2014-03-19 Institut Quimic De Sarria Bioactive implant
US20110295249A1 (en) * 2010-05-28 2011-12-01 Salient Surgical Technologies, Inc. Fluid-Assisted Electrosurgical Devices, and Methods of Manufacture Thereof
US9138289B2 (en) 2010-06-28 2015-09-22 Medtronic Advanced Energy Llc Electrode sheath for electrosurgical device
US8920417B2 (en) 2010-06-30 2014-12-30 Medtronic Advanced Energy Llc Electrosurgical devices and methods of use thereof
US8906012B2 (en) 2010-06-30 2014-12-09 Medtronic Advanced Energy Llc Electrosurgical devices with wire electrode
US9023040B2 (en) 2010-10-26 2015-05-05 Medtronic Advanced Energy Llc Electrosurgical cutting devices
US9427281B2 (en) 2011-03-11 2016-08-30 Medtronic Advanced Energy Llc Bronchoscope-compatible catheter provided with electrosurgical device
US10052218B2 (en) 2011-04-18 2018-08-21 Vascular Graft Solutions Ltd. Devices and methods for deploying implantable sleeves over blood vessels
CN103747751B (en) 2011-06-08 2016-12-28 森特里心脏股份有限公司 Knot of tissue bundling device and tensioner thereof
US9750565B2 (en) 2011-09-30 2017-09-05 Medtronic Advanced Energy Llc Electrosurgical balloons
US8870864B2 (en) 2011-10-28 2014-10-28 Medtronic Advanced Energy Llc Single instrument electrosurgery apparatus and its method of use
US9277905B2 (en) * 2012-08-02 2016-03-08 W. L. Gore & Associates, Inc. Space-filling device
WO2014127278A2 (en) * 2013-02-18 2014-08-21 Elutin, Inc. Site specific drug delivery wraps, systems and methods of use thereof
EP3378416B1 (en) 2013-03-12 2020-07-29 Sentreheart, Inc. Tissue ligation devices
US20140276054A1 (en) * 2013-03-15 2014-09-18 Volcano Corporation Piezoelectric-Actuated Fluid-Delivery Devices and Associated Systems and Methods
US9526503B2 (en) * 2013-08-12 2016-12-27 W. L. Gore & Associates, Inc. Lumbar ostia occlusion devices and methods of deploying the same
EP3062711B1 (en) 2013-10-31 2023-06-21 AtriCure, Inc. Devices for left atrial appendage closure
US10842988B2 (en) * 2014-06-02 2020-11-24 Medtronic, Inc. Over-the-wire delivery of a substernal lead
US9974599B2 (en) 2014-08-15 2018-05-22 Medtronic Ps Medical, Inc. Multipurpose electrosurgical device
WO2016154488A2 (en) 2015-03-24 2016-09-29 Sentreheart, Inc. Tissue ligation devices and methods therefor
CN107530070B (en) 2015-03-24 2021-09-28 森特里心脏股份有限公司 Device and method for left atrial appendage closure
US20170042551A1 (en) 2015-08-13 2017-02-16 The Brain Protection Company PTY LTD Implantable damping devices for treating dementia and associated systems and methods of use
US11389227B2 (en) 2015-08-20 2022-07-19 Medtronic Advanced Energy Llc Electrosurgical device with multivariate control
US11051875B2 (en) 2015-08-24 2021-07-06 Medtronic Advanced Energy Llc Multipurpose electrosurgical device
US10433870B2 (en) 2015-10-08 2019-10-08 Medtronic, Inc. Interventional medical systems and methods for delivering a medical electrical lead to an epicardial implant site
US10327812B2 (en) 2015-11-04 2019-06-25 Rainbow Medical Ltd. Pericardial access device
US10716612B2 (en) 2015-12-18 2020-07-21 Medtronic Advanced Energy Llc Electrosurgical device with multiple monopolar electrode assembly
JP7137472B2 (en) 2016-02-26 2022-09-14 センターハート・インコーポレイテッド Device and method for left atrial appendage closure
WO2018057963A1 (en) 2016-09-23 2018-03-29 Sentreheart, Inc. Devices and methods for left atrial appendage closure
US10194975B1 (en) 2017-07-11 2019-02-05 Medtronic Advanced Energy, Llc Illuminated and isolated electrosurgical apparatus
US10667842B2 (en) 2017-11-24 2020-06-02 Rainbow Medical Ltd. Pericardial needle mechanism
US11844526B2 (en) 2018-03-27 2023-12-19 Atricure, Inc. Devices and methods for left atrial appendage closure

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923060A (en) * 1974-04-23 1975-12-02 Jr Everett H Ellinwood Apparatus and method for implanted self-powered medication dispensing having timing and evaluator means
US4003379A (en) * 1974-04-23 1977-01-18 Ellinwood Jr Everett H Apparatus and method for implanted self-powered medication dispensing
US4250878A (en) * 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
DK149080C (en) * 1980-06-06 1986-07-28 Sankyo Co METHOD FOR PREPARING ML-236B CARBOXYLIC ACID DERIVATIVES
US4411648A (en) * 1981-06-11 1983-10-25 Board Of Regents, The University Of Texas System Iontophoretic catheter device
US4423725A (en) * 1982-03-31 1984-01-03 Baran Ostap E Multiple surgical cuff
DE3325797A1 (en) * 1983-07-16 1985-01-31 Natec Inst Naturwiss Balloon-tipped catheter, especially an endotracheal catheter
ZA85332B (en) * 1984-01-20 1985-09-25 Cedars Sinai Medical Center Method of treatment of the myocardium and catheter for retroinfusion of pharmacologic agents
US4809707A (en) * 1985-04-12 1989-03-07 Kvm Engineering, Inc. Electrode for non-invasive allergy testing
US4637815A (en) * 1985-08-06 1987-01-20 Lemole Gerald M Irrigational hemostatic solution
ATE84419T1 (en) * 1985-09-24 1993-01-15 Item Dev Ab CONTINUOUS INTRAVENOUS INFUSION OF ADENOSIN IN HUMAN PATIENTS, UNIT DOSAGE FORM OF ADENOSIN AND ITS USE IN PHARMACEUTICAL PRODUCTION.
JPS63502112A (en) * 1986-01-03 1988-08-18 コンソリデイテツド・フアーマシユーテイカルズ・リミテツド Melphalan derivative
JPH06696B2 (en) * 1987-01-27 1994-01-05 積水化学工業株式会社 Tape preparation
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
US5163905A (en) * 1990-01-12 1992-11-17 Don Michael T Anthony Regional perfusion dissolution catheter
US5176638A (en) * 1990-01-12 1993-01-05 Don Michael T Anthony Regional perfusion catheter with improved drug delivery control
US5236413B1 (en) * 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
WO1991019529A1 (en) * 1990-06-15 1991-12-26 Cortrak Medical, Inc. Drug delivery apparatus and method
US5279546A (en) * 1990-06-27 1994-01-18 Lake Region Manufacturing Company, Inc. Thrombolysis catheter system
US5178608A (en) * 1990-09-24 1993-01-12 Advanced Biomedical Devices, Inc. Balloon catheter with expandable inflation member
JPH04330012A (en) * 1991-01-24 1992-11-18 Kitsuen Kagaku Kenkyu Zaidan Coronary vasodilator
US5318531A (en) * 1991-06-11 1994-06-07 Cordis Corporation Infusion balloon catheter
US5222936A (en) * 1991-09-25 1993-06-29 Stephen Robert L Intracorporeal iontophoretic method
JPH0596012A (en) * 1991-10-07 1993-04-20 Olympus Optical Co Ltd Thermotherapic device
US5304120A (en) * 1992-07-01 1994-04-19 Btx Inc. Electroporation method and apparatus for insertion of drugs and genes into endothelial cells
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
US5650447A (en) * 1992-08-24 1997-07-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nitric oxide-releasing polymers to treat restenosis and related disorders
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US5403834A (en) * 1992-12-07 1995-04-04 Eukarion, Inc. Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
US5397307A (en) * 1993-12-07 1995-03-14 Schneider (Usa) Inc. Drug delivery PTCA catheter and method for drug delivery

Also Published As

Publication number Publication date
AU3134095A (en) 1996-01-19
DE69534798T2 (en) 2006-10-26
WO1996000112A1 (en) 1996-01-04
WO1996000038A1 (en) 1996-01-04
EP0766580A1 (en) 1997-04-09
EP0766580A4 (en) 2001-06-27
JPH10507092A (en) 1998-07-14
US5681278A (en) 1997-10-28
CA2193836C (en) 2010-03-30
DE69534798D1 (en) 2006-04-27
US5634895A (en) 1997-06-03
AU3134495A (en) 1996-01-19
EP0766580B1 (en) 2006-02-22
ATE318164T1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
CA2193836A1 (en) Vascular treatment method and apparatus
US5941868A (en) Localized intravascular delivery of growth factors for promotion of angiogenesis
Bates et al. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
US5112305A (en) Catheter device for intramural delivery of therapeutic agents
US7381731B2 (en) Pharmaceutical composition comprising citrulline
KR0156597B1 (en) Method and composition for ameliorating tissue damage due to ischemia and reperfusion
Grech et al. Termination of reperfusion arrhythmia by coronary artery occlusion.
Maksimenko et al. The combination of modified antioxidant enzymes for anti-thrombotic protection of the vascular wall: the significance of covalent connection of superoxide dismutase and catalase activities
Capurro et al. Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs.
Goldberg et al. Combination therapy for evolving myocardial infarction: Intracoronary thrombolysis and percutaneous transluminal angioplasty
WO1998030255A9 (en) Localized intravascular delivery of antioxidant substances for inhibition of restenosis in recanalized blood vessels
Klevan et al. Coronary vasospasm culminating in thromboels and infarction following “successful” coronary angioplasty
Knight et al. Interrelationships between prostanoids and skin flap survival: a review
Schumacher et al. Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis
Rentrop et al. Recanalization of Coronary Arteries by Thrombolytic Agents in Acute Myocardial Infarction
Beyersdorf Protection of evolving myocardial infarction and failed PTCA
Kerensky et al. Lysis of intravascular thrombus prior to coronary stenting using the dispatch infusion catheter
Werter et al. Coronary reperfusion with a new catheter in six patients with acute occlusion after angioplasty
Friedman Early interventions in the management of acute uncomplicated myocardial infarction.
WO1999002219A1 (en) Method and system for the intramural delivery of radioactive agents
Meerbaum Surgical modes of retroperfusion
Betriu et al. Thrombolysis in Acute Myocardial Infarction
SU1695929A1 (en) Method of myocardial infarction treatment
Haneda et al. Coronary sinus norepinephrine level during angina pectoris induced by atrial pacing
Numano et al. Effects of thromboxane A2 (TXA2) on hemodynamic and biochemical parameters of canine hearts

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140625